Seyltx

Seyltx is a privately held drug development company based in the United States. The company focuses on developing treatments for the central nervous system, primarily concentrating on modulating neural receptors to address unmet medical needs in areas such as pulmonary diseases. Seyltx’s goal is to rapidly advance the development of treatments that have already obtained human safety and efficacy data to meet healthcare demands affecting large populations worldwide.